Skip to main content

Lebensqualität in der Uroonkologie

  • Chapter
Uroonkologie
  • 388 Accesses

Auszug

Lebensqualität (LQ)ist nach der Überlebenszeit das wichtigste Behandlungsziel für Krebspatienten. Dies gilt von der Diagnosestellung an für den gesamten Krankheits- und Behandlungsverlauf.Für Patienten mit nicht malignen bzw.nicht lebensbedrohlichen Erkrankungen sind Lebensqualität oder spezifische Aspekte davon primäre Therapieziele. Gesundheitsbezogene Lebensqualität ist heute mit naturwissenschaftlichen Methoden zuverlässig messbar.Es lassen sich so Auswirkungen von Krankheit und Therapie systematisch darstellen und vergleichen. Dies gilt insbesondere für die Uroonkologie,aber auch für das Gesamtgebiet “Urologie„.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aaronson NK, Ahmedzai S, Bergman B(1993) The European Organization for Research and Treatment of Cancer. QLQ C-30: A Quality of Life Instrument for use in International clinical Trials in Oncology. J Natl Cancer Inst 85: 365–376

    Article  PubMed  CAS  Google Scholar 

  • Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland in Zusammenarbeit mit dem Robert Koch Institut (Hrsg Krebs in Deutschland-Häufigkeiten und Trends 4, überarbeitete, aktualisierte Ausgabe. Saarbrücken2004

    Google Scholar 

  • Atzpodien J, Kuechler T, Wandert T, Reitz M(2003) Rapid deterioration in quality of life during interleukin-2-and a-interferon-based home therapy of renal cell carcinoma is associated with a good outcome. British Journal of Cancer:89,50–54

    Article  PubMed  CAS  Google Scholar 

  • Bestmann B, Rohde V, Siebmann JU, Galalae R, Weidner W, Kuchler T(2006) Validation of the German prostate-specific module. World J Urol Jan 19: 17[Epubaheadofprint]

    Google Scholar 

  • Biermann CW; Küchler T(1999) Lebensqualität in der urologischen Onkologie. Urologe[A] 38: 189–200

    Google Scholar 

  • Biermann CW, Schmidt C, Kuechler T(1995) Development of a life quality questionnaire in bladder cancer surgery. BritishJournalofUrology 79: 411–413

    Google Scholar 

  • Boeckmann W, Jakse G:Nierenzellkarzinom.In:Rübben H(Hrsg):Uro Onkologie,3.vollständigüberarbeiteteAuflage, Springer Verlag 2001

    Google Scholar 

  • Bullinger M (1995) German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med 1995 Nov;41(10): 1359–1366

    CAS  Google Scholar 

  • Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon Jetal.(1993) TheFunctional Assessment of Cancer Therapyscale:development and validation of the general measure. J Clin Onco lMar;11(3): 570–579

    CAS  Google Scholar 

  • Dahl AA, Mykletun A, Fossa SD(2005) Quality of life in survivor softes-ticular cancer. Urol Oncol May Jun;23(3): 193–200.Review

    Google Scholar 

  • Davis JW, Kuban DA, Lynch DF, Schellhammer PF(2001) Quality of life after treatment for localized prostate cancer:differences based on treatment modality. J UrolSep;166(3): 947–952

    Article  CAS  Google Scholar 

  • Deutsche Krebsgesellschaft (1990):Konsensus-Konferenz: Erfassung von Lebensqualität in der Onkologie-Konzepte Methodik und Anwendung 3: 7–10

    Google Scholar 

  • Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, Dhaese S, Zurlo A(2003) Beyond the development of health-related quality-of-life(HRQOL)measures:a check list for evaluating HRQOL out comes in cancer clinical trial sdoes HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol Sep 15;21(18): 3502–3511

    Google Scholar 

  • Fegg MJ, Gerl A, Vollmer TC, Gruber U, Jost C, Meiler S, Hiddemann W(2003) Subjektive Quality of Life and sexual functioning after germ-cell tumour therapy. British Journal of Cancer 89(12): 2002–2006

    Article  Google Scholar 

  • Fleer J, Hoekstra HJ, Sleijfer DT,Hoekstra-Weebers JEHM: Quality of life of survivors of testicular germ cell cancer. Support Care Cancer(2004)12: 476–486

    Article  PubMed  CAS  Google Scholar 

  • Fossa SD, deWit R, Roberts T, Wilkinson PT, deMulder PHM, Mead GM, Cook P, dePrijk L, Stenning S, Aaronson NK, Bottomley A, Colette L(2003) Quality of Life in Good Prognosis Patients with Metastatic Germ Cell Cancer: A Prospective Study of the European Organization fro Research and Treatment of Cancer Genitourinary Group/ Medical Research Cuncil Testicular Cancer Study Group (30941/ TE20). J Clin Oncol 21(6): 1107/1118

    Article  Google Scholar 

  • Fulmer BR, Bissonette EA, Petroni GR, Theodorescu D(2001) Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy. CancerJun1;91(11): 2046–55

    Article  CAS  Google Scholar 

  • Henrich G; Herschbach P(2000) Articles-Questions on Life Satisfaction (FLZM) A Short Questionnaire for Assessing Subjective Quality of Life European journal of psychological assessment, Bd.16,3: 150–159

    Google Scholar 

  • Krupski T, Petroni GR, Bissonette EA, Theodorescu D(2000) Quality-oflife comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology May;55(5): 736–42

    Article  CAS  Google Scholar 

  • Küchler, Th., Schreiber, H.W(1989) “Lebensqualität in der Allgemeinchirurgie-Konzepte und praktische Möglichkeiten der Messung„,HÄB 43,246–250

    Google Scholar 

  • Lebeau T, Perrotte P, Valiquette L, Benard F, McCormack M, Saad F, Karakiewicz PI (2005) Validation of prostate cancer index and SF-12 short forms Can J Urol Dec;12(6): 2873–9

    Google Scholar 

  • Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH(1998) The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care Jul;36(7): 1002–12

    Article  CAS  Google Scholar 

  • Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM(1999) Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology Sep;54(3): 503–8

    Article  CAS  Google Scholar 

  • McCammon KA, Kolm P, Main B, Schellhammer PF(1999) Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology Sep;54(3): 509–16

    Article  CAS  Google Scholar 

  • Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Resnick MI, Smalley SR etal. (1995) Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association J Urol Dec;154(6): 2144–8

    CAS  Google Scholar 

  • Preiß J, Dornoff W, Hagmann FG, Schmieder A (2004) Onkologie 2004/2005-Interdisziplinäre Empfehlungen zur Therapie. 12. Auflage, Zuckschwerdt, München Wien New York

    Google Scholar 

  • Spilker B (ed) (1996) Quality of life and pharmacoeconomics in clinical trials.Lippincott-Raven Philadelphia

    Google Scholar 

  • Stockler MR, Osoba D, Corey P, Goodwin PJ, Tannock IK(1999) Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. J Clin Epidemiol Jul;52(7): 653–66

    Article  CAS  Google Scholar 

  • Tamburini M, Filiberti A, Barbieri A, Zanoni F, Pizzocaro G, Barletta L, Ventafridda V (1989) Psychological aspects of testis cancer therapy: a prospective study. J Urol 142: 1487–1489

    PubMed  CAS  Google Scholar 

  • Ware JEJr, Sherbourne CD(1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care Jun;30(6): 473–83

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Küchler, T., Bestmann, B. (2007). Lebensqualität in der Uroonkologie. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33848-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33848-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33847-5

  • Online ISBN: 978-3-540-33848-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics